Cenk SumenChief Technology Officer at Stemson Therapeutics
Cenk Sumen, PhD, is Chief Technology Officer of Stemson Therapeutics. He is a globally recognized expert in gene and cell therapy manufacturing and automation, working closely with cell therapy developers to support strategic consulting and clinical manufacturing while serving as a technical and business development leader in industry and teaching immunology to engineering students at NYU Tandon. Prior to joining Stemson, Cenk served as the Director of Business Development for the BioProduction Division at ThermoFisher. He currently serves in the Outreach & Communication (former Chair) and Publication Committees at ASGCT. Cenk earned his BS in Biology at MIT and his PhD in Microbiology & Immunology at Stanford University, completing post-doctoral studies in intravital imaging at Harvard Medical School and cancer immunology at Memorial Sloan-Kettering Cancer Center.